Suppr超能文献

早期声门癌累及前联合采用改良激光声带切除术治疗的肿瘤学结局

Oncologic outcomes of early glottic cancers with anterior commissure involvement treated with advanced laser cordectomies.

作者信息

Dhambri Sawssen, Dhaha Mohamed, Tibini Makram, Jbali Souheil, Kedous Skander, Touati Slim, Gritli Said

出版信息

Tunis Med. 2019 Aug-Sep;97(8-9):978-983.

Abstract

INTRODUCTION

The contribution of transoral laser microsurgery (TLM) in the management of early glottic cancer is now well established. The anterior commissure (AC) is a delicate anatomic subsite due to its difficult access and the high risk of tumour spread from this site to the thyroid cartilage, the subglottis and the pre epiglottic space. These reasons make the endoscopic approach controversial in case of AC involvement.

METHODS

This is a single centre retrospective study performed between the years 2012 and 2015. Eighteen patients treated with advanced Va laser cordectomies were included.

RESULTS

All tumours were staged T1 (78% were T1a and 12% T1b). After laser surgery 4 patients (22.22%) had positive margins. These patients were candidate to second look procedure allowing detection and treatment of residual disease.  Oncologic outcomes were studied. Two patients experienced local relapses within a mean delay of 7 months. The local control rate was 88.9% while the local control using laser only was 83.33%. One patient underwent a total laryngectomy (TL) followed by adjuvant radiation therapy (RT) after a massive recurrence in the AC with infiltration of the thyroid cartilage. The laryngeal preservation rate was 94.44%. The 3 years overall survival rate reached 100% while the 3 years disease free survival was 88.9%.

CONCLUSION

the TLM offers acceptable oncologic outcomes in the treatment of T1 laryngeal cancer with AC involvement.

摘要

引言

经口激光显微手术(TLM)在早期声门癌治疗中的作用现已得到充分证实。由于前联合(AC)难以暴露且肿瘤从该部位扩散至甲状软骨、声门下区和会厌前间隙的风险较高,因此它是一个精细的解剖亚部位。这些原因使得在内镜治疗涉及AC的病例时存在争议。

方法

这是一项在2012年至2015年间进行的单中心回顾性研究。纳入了18例行晚期Va型激光声带切除术的患者。

结果

所有肿瘤均为T1期(78%为T1a期,12%为T1b期)。激光手术后,4例患者(22.22%)切缘阳性。这些患者需接受二次手术以检测和治疗残留疾病。对肿瘤学结局进行了研究。2例患者在平均7个月的时间内出现局部复发。局部控制率为88.9%,而单纯使用激光的局部控制率为83.33%。1例患者在AC出现大量复发并侵犯甲状软骨后接受了全喉切除术(TL),随后进行了辅助放疗(RT)。喉保留率为94.44%。3年总生存率达到100%,3年无病生存率为88.9%。

结论

TLM在治疗累及AC的T1期喉癌时可提供可接受的肿瘤学结局。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验